MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Novartis AG Company Profile (NYSE:NVS)

Consensus Ratings for Novartis AG (NYSE:NVS) (?)
Ratings Breakdown: 2 Sell Rating(s), 9 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.13)
Consensus Price Target: $93.00 (16.85% upside)

Analysts' Ratings History for Novartis AG (NYSE:NVS)
Show:
DateFirmActionRatingPrice TargetActions
5/26/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2016Citigroup Inc.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2016Bank of AmericaReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016Leerink SwannReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2016BarclaysUpgradeUnderweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2016Credit SuisseReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Morgan StanleyDowngradeEqual Weight -> UnderweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/5/2016ArgusInitiated CoverageHold -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2016BNP ParibasDowngradeOutperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Goldman SachsBoost Price TargetNeutral$89.00 -> $92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/23/2015VontobelDowngradeHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2015Sanford C. BernsteinLower Price TargetOutperform$102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2015Main First Bank AGDowngradeUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2015Oddo SecuritiesInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2015HSBCInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015Bryan, Garnier & CoUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2015NatixisUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015Cowen and CompanyUpgradeMarket Perform -> Outperform$95.00 -> $105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2014Kepler Capital MarketsUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Novartis AG (NYSE:NVS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
4/21/2016Q116$1.18$1.17$11.90 billion$11.60 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2016Q415$1.18$1.14$12.64 billion$12.52 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315$1.31$1.27$12.66 billion$12.30 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/21/2015Q215$1.20$1.27$12.45 billion$12.70 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015Q115$1.10$1.33$12.90 million$11.94 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2015Q314$1.21$1.21$14.68 billion$14.63 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2014Q3$1.31$1.33$14.51 billion$14.70 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/17/2014Q214$1.36$1.36$14.83 billion$14.64 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014$1.27$1.31$14.25 billion$14.02 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2014Q413$1.27$1.20$15.16 billion$15.08 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2013Q313$1.31$1.26$14.28 billion$14.34 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/17/2013Q213$1.29$1.30$14.39 billion$14.50 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2013Q113$1.28$1.32$14.02 million$14.02 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/23/2013Q412$1.19$1.27$14.42 billion$14.80 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012$1.34$1.34ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/19/2012$1.33$1.38ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2012$1.30$1.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/25/2012$1.26$1.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011$1.45$1.45ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/19/2011$1.46$1.48ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/19/2011$1.30$1.41ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2011$1.25$1.14ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Novartis AG (NYSE:NVS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$1.17$1.18$1.17
Q2 20162$1.12$1.21$1.17
Q3 20162$1.20$1.32$1.26
Q4 20162$1.13$1.24$1.19
(Data provided by Zacks Investment Research)
Current Dividend Information for Novartis AG (NYSE:NVS)
Annual Dividend:$2.76
Dividend Yield:3.47%
Payout Ratio:57.38%
Dividend Growth:2.40% (3 Year Average)

Dividend History for Novartis AG (NYSE:NVS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
2/1/2016Annual$2.342/24/20162/26/20162/26/2016Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014annual$2.723.48%2/27/20143/3/20143/11/2014Tweet This Announcement  Share This Announcement on StockTwits
2/11/2013annual$2.533.71%2/26/20132/28/20134/5/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Novartis AG (NYSE:NVS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/11/2016Institutes For Biomed NovartisMajor ShareholderBuy277,777$18.00$4,999,986.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2016Bioventures Ltd NovartisMajor ShareholderBuy375,000$8.00$3,000,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/22/2014Bioventures Ltd NovartisMajor ShareholderBuy325,000$15.00$4,875,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Novartis AG (NYSE:NVS)
DateHeadline
06/29/16 08:25 AMXencor (XNCR) and Novartis (NVS) Team Up to Beat Blood Cancer
06/29/16 08:08 AMInside the CHMP’s Refusal of Novartis’s Arzerra as a Maintenance Treatment -
06/28/16 05:32 PMXencor, Novartis In Collaboration, License Deal For Bispecific Antibodies
06/28/16 05:23 PMXencor signs cancer-drug deal with Novartis; its stock surges 32% -
06/28/16 10:24 AMNovartis AG Stock Price Update Today (NVS) - June 28, 2016 - Money Morning
06/27/16 05:27 PMAperio Group LLC Decreased Stake in Novartis Ag Sponsored (NYSE:NVS) by $7.11 Million as Shares Declined - Press Telegraph
06/27/16 05:27 PMShares of Novartis AG (NYSE:NVS) Sees Large Inflow of Net Money Flow - Trade Calls
06/25/16 09:16 AMNovartis AG (NYSE:NVS): The Buzzing Stock - Stocks Daily
06/25/16 09:16 AMRecent Analysts Moves of Stocks: Novartis AG (NYSE:NVS) , Intrexon Corporation (NYSE:XON) - Street Updates
06/25/16 09:16 AMNovartis AG Stock Price Update Today (NVS) - June 25, 2016 - Money Morning
06/24/16 05:29 PMIncyte Gains on Jakafi's Breakthrough Status for Acute GVHD
06/24/16 04:21 PMBrexit Sell-Off Hits 3 Big Pharma Bargain Stocks -
06/24/16 08:08 AMHow Many Heart Failure Deaths Can Novartis AG (ADR) (NYSE:NVS) Entresto Reduce?
06/23/16 04:50 PMIs this the drug answer to Alzheimer's and Huntington's disease? -
06/23/16 08:15 AMPerformance to see: Novartis AG (NYSE:NVS) - News Oracle
06/23/16 08:15 AMHC Stocks Reports: Pernix Therapeutics Holdings Inc (NASDAQ:PTX), Novartis AG (ADR) (NYSE:NVS) - share market updates (press release)
06/23/16 08:15 AMHow Many Heart Failure Deaths Can Novartis AG (ADR) (NYSE:NVS) Entresto Reduce? - Market Exclusive
06/23/16 08:15 AMNovartis AG Stock Price Update Today (NVS) - June 23, 2016 - Money Morning
06/22/16 05:28 PMPartnerships propel Stellar Biotechnologies' vaccine technology
06/22/16 10:17 AMHC Stocks Vigilant: CIGNA Corporation (NYSE:CI), Novartis AG (ADR) (NYSE:NVS) - share market updates (press release)
06/22/16 10:17 AMNovartis AG Stock Price Update Today (NVS) - June 21, 2016 - Money Morning
06/22/16 10:17 AMNovartis AG Stock Price Update Today (NVS) - June 22, 2016 - Money Morning
06/21/16 09:59 AMNovartis AG (NYSE:NVS) Raises $60 Million For F2G - Market Exclusive
06/18/16 04:51 PMNovartis AG Stock Price Update Today (NVS) - June 18, 2016 - Money Morning
06/17/16 08:19 AMBuy Sell or Hold? - Starbucks Corporation (NASDAQ:SBUX), Novartis AG (NYSE:NVS) - Beacon Chronicle
06/17/16 08:19 AMNovartis AG Stock Price Update Today (NVS) - June 17, 2016 - Money Morning
06/16/16 05:44 PMNovartis AG Stock Price Update Today (NVS) - June 16, 2016 - Money Morning
06/16/16 09:46 AMMalaria:Novartis expands partnership with Medicines for Malaria Venture to develop next-generation antimalarial treatment
06/16/16 09:46 AMNovartis To Lead Development Of KAF156 With Medicines For Malaria Venture
06/15/16 05:30 PMAnalyst Opinion on these Stocks: Novartis AG (NYSE:NVS), Teekay Tankers Ltd. (NYSE:TNK) - Beacon Chronicle
06/15/16 10:07 AMNoteworthy Analyst's Rating to Observe: Mast Therapeutics, Inc. (NYSEMKT:MSTX) , Novartis AG (NYSE:NVS) - Street Updates
06/15/16 10:07 AMNovartis AG Stock Price Update Today (NVS) - June 14, 2016 - Money Morning
06/15/16 10:07 AMNovartis AG Stock Price Update Today (NVS) - June 15, 2016 - Money Morning
06/14/16 05:17 PMARIAD (ARIA) Presents Long-Term Phase II Data on Iclusig
06/14/16 10:21 AMAmgen's Biosimilar of AbbVie's Humira to Face FDA Panel
06/11/16 08:25 AMAnalyst's Checklist Stocks: Novartis AG (NYSE:NVS) , LDR Holding Corporation (NASDAQ:LDRH) - Street Updates
06/11/16 08:25 AMNovartis AG Stock Price Update Today (NVS) - June 11, 2016 - Money Morning
06/11/16 08:25 AMColombia Makes Good On Its Threat Against Novartis AG (NVS) - Insider Monkey (blog)
06/10/16 03:27 PMColombia Makes Good On Its Threat Against Novartis AG (NVS) -
06/10/16 08:29 AMRecent Trading Updates: Intrexon Corporation (NYSE:XON) , Novartis AG (NYSE:NVS) - Street Updates
06/10/16 08:29 AMNovartis AG Stock Price Update Today (NVS) - June 10, 2016 - Money Morning
06/10/16 08:06 AMAn Inside Look at Incyte’s Product Portfolio -
06/09/16 05:53 PMTraders Targeted Movers: Novartis AG (NYSE:NVS) , CytRx Corporation (NASDAQ:CYTR) - Street Updates
06/09/16 05:15 PMColombia to force Novartis to lower prices of cancer drug -
06/09/16 04:56 PMColombia to set new price for Novartis cancer drug -minister - [Reuters] - Colombia will set a new price for the Novartis cancer drug imatinib in a bid to cut healthcare costs after price negotiations with the Swiss company broke down, the health minister said on Thursday. A so-called public interest declaration for imatinib will allow health regulators to examine the case and set a new, lower price for the drug. Colombia stopped short of declaring a compulsory license, which would have overridden Novartis' patent and permitted other companies to make cheaper generic versions.
06/09/16 08:31 AMNovartis AG Stock Price Update Today (NVS) - June 09, 2016 - Money Morning
06/08/16 05:58 PMEarnings Overview of the Stocks: Novartis AG (NYSE:NVS), Amphenol Corporation (NYSE:APH) - Beacon Chronicle
06/08/16 08:32 AMNovartis AG Stock Price Update Today (NVS) - June 08, 2016 - Money Morning
06/07/16 08:15 AMNovartis AG Stock Price Update Today (NVS) - June 07, 2016 - Money Morning
06/06/16 05:28 PMWPP plc (NASDAQ:WPPGY) unit acquires ePromode: Novartis AG (NYSE:NVS), Alibaba Group (NYSE:BABA), Netflix ... - KC Register
About Novartis AG

Novartis AG logoNovartis AG is a holding company that, through its subsidiaries, is engaged in development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals around the world. Its portfolio includes medicines, eye care, generic pharmaceuticals, preventive vaccines and over-the-counter (OTC) products. The Company's segments include Pharmaceuticals, which include patent-protected prescription medicines; Alcon, which include surgical, ophthalmic pharmaceutical and vision care products; Sandoz, which include generic pharmaceuticals, and Consumer Health, which includes the OTC Division. Pharmaceuticals products include Afinitor/Votubia, Exjade, Galvus, Exforge and Voltaren, among others. Its Sandoz products include Valsartan (Diovan), Cyclophosphamide injection and AirFluSal Forspiro, among others. Its OTC offers readily available consumer medicine. The Company operates Admune Therapeutics as a wholly owned subsidiary.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: NVS
  • CUSIP:
Key Metrics:
  • Previous Close: $79.59
  • 50 Day Moving Average: $78.19
  • 200 Day Moving Average: $77.35
  • P/E Ratio: 28.38
  • P/E Growth: 2.67
  • Market Cap: $189.53B
  • Current Quarter EPS Consensus Estimate: $4.83 EPS
Additional Links:
Novartis AG (NYSE:NVS) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha